Table 2 Least square means (LSM ± S.E) of plasma metabolites as influenced by CDCO treatment and week of supplementation
Effect | Plasma metabolites | |||
|---|---|---|---|---|
BHBA | Cholesterol | Glucose | NEFA | |
Control | 0.5 ± 0.0a | 5.8 ± 0.2 | 3.9 ± 0.1 | 0.2 ± 0.0 |
High | 0.5 ± 0.0a | 5.6 ± 0.3 | 3.9 ± 0.1 | 0.2 ± 0.0 |
Low | 0.4 ± 0.0b | 5.3 ± 0.3 | 3.7 ± 0.2 | 0.1 ± 0.0 |
Medium | 0.4 ± 0.0b | 5.5 ± 0.2 | 3.9 ± 0.1 | 0.2 ± 0.0 |
Week | Â | Â | Â | Â |
0 | 0.4 ± 0.0 | 5.5 ± 0.2 | 4.1 ± 0.1 | 0.2 ± 0.0 |
2 | 0.6 ± 0.0 | 5.6 ± 0.2 | 4.0 ± 0.1 | 0.1 ± 0.0 |
3 | 0.4 ± 0.0 | 5.6 ± 0.3 | 3.8 ± 0.1 | 0.2 ± 0.0 |
5 | 0.6 ± 0.0 | 5.5 ± 0.3 | 4.0 ± 0.1 | 0.1 ± 0.0 |
7 | 0.4 ± 0.0 | 5.3 ± 0.5 | 3.5 ± 0.2 | 0.2 ± 0.0 |
8 | 0.4 ± 0.0 | 5.7 ± 0.4 | 3.7 ± 0.1 | 0.1 ± 0.0 |